Work

Use of tumour-responsive T cells as cancer treatment

Year: 2009

Type: article

Source: The Lancet

DOI: 10.1016/s0140-6736(09)60404-9

Authors: Mary L Disis, Helga Bernhard, Elizabeth M Jaffee

Institutions: University of Washington, TUM Klinikum, Helmholtz Munich, Technical University of Munich, Johns Hopkins University

Language: English

Topic: Immunotherapy and Immune Responses

Subfield: Immunology

Field: Immunology and Microbiology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: green

Funders: Wilhelm Sander-Stiftung, National Institute for Health and Care Research, National Institutes of Health, National Cancer Institute, National Center for Advancing Translational Sciences

Awards: G1224401398, G1324540468, G1389856746, G1973266902, G2528120253, Institute of Translational Health Sciences, G4129328755, G4178682855, G4532454588, G5620430685, G691201058, G7920114764, SPORE in Gastrointestinal Cancers, G970037175

OpenAlex ID: W2155477398

FWCI: 8.778

Cites: 133

Cited by: 164

Related to: 10